Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2013 May;121(5):919-920.
doi: 10.1097/AOG.0b013e31828e8bf1.

The intrauterine device: a good thing revisited

David E Soper  1
Affiliations
Editorial

The intrauterine device: a good thing revisited

David E Soper. Obstet Gynecol. 2013 May.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Finer LB, Jerman J, Kavanaugh ML. Changes in use of long-acting contraceptive methods in the United States, 2007-2009. Fertil Steril 2012;98:893–7.
    1. Gupta J, Kai J, Middleton L, Pattison H, Gray R, Daniels J; ECLIPSE Trial Collaborative Group. Levonorgestrel intrauterine system versus medical therapy for menorrhagia. N Engl J Med 2013;368:128–37.
    1. Sørdal T, Inki P, Draeby J, O´Flynn M, Schmelter T. Management of initial bleeding or spotting after levonorgestrel-releasing intrauterine system placement: a randomized controlled trial. Obstet Gynecol 2013;121:934–41.
    1. Wong AWY, Chan SSC, Yeo W, Yu M-Y, Tam W- H. Prophylactic use of levonorgestrel-releasing intrauterine system in women with breast cancer treated with tamoxifen: a randomized controlled trial. Obstet Gynecol 2013;121:943–50.
    1. Hubacher D, Grimes DA, Gemzell-Danielsson K. Pitfalls of research linking the intrauterine device to pelvic inflammatory disease. Obstet Gynecol 2013;121:1091–8.

MeSH terms

LinkOut - more resources